PCI and Experic, a contract manufacturing organization (CMO) and pharmaceutical supply service company, are joining forces with a strategic, synergistic partnership involving clinical and commercial manufacturing, packaging and supply chain services.
The agreement will give Experic access to PCI’s clinical and commercial supply chain capabilities and strong presence in Europe. In turn, Experic will provide PCI access to advanced powder-filling equipment and capabilities including low dose filling for inhalation and other delivery modalities. This partnership will enhance the growth and success of both organizations.
“We’re extremely pleased to be working with Experic, whose expertise in dry powder inhalation and other scalable manufacturing solutions will mean added value for our clients and our future as a company,” said Salim Haffar, CEO, PCI Pharma Services.
“Sharing capabilities and collaborating on services will allow our respective differentiators to complement one another, strengthening both companies, and allowing us to provide patients new and better treatments within a complex drug supply chain ecosystem.”
“This exciting partnership with PCI, a leading global outsourcing solutions provider to pharma and biopharma companies, facilitates a rapid expansion of the services we offer to clients. It’s a partnership that makes sense for both organizations – providing access to solutions that help each company expand its portfolio of offerings to clients,” said Jeff McMullen, CEO, Experic.
Under the reciprocal agreement, Experic will have access to PCI’s integrated full services in the EU, including the PCI European quality control team, providing their clients access to manufacturing, packaging, storage and delivery services that facilitate clinical trials in the region.
For PCI, Experic brings state-of-the-art manufacturing technologies and filling equipment for micro-dosing through its partnership with Germany-based Harro Höfliger. Experic’s low dose powder filling capabilities will also enable the efficient transition of products from clinical to commercial-scale manufacturing.
Please feel free to contact the PCI team firstname.lastname@example.org